View Older Stories View More Recent Stories

Nov 12, 2020 06:30AM Zomedica Announces Third Quarter 2020 Financial Results
Oct 26, 2020 09:25AM Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Special Virtual-Only Meeting
Oct 2, 2020 05:05PM Zomedica Announces Name Change
Sep 25, 2020 11:00AM Zomedica Announces Shareholder Meeting Voting Results
Sep 10, 2020 06:55AM Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference
Sep 8, 2020 06:55AM Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA™
Aug 27, 2020 06:55AM Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Special Virtual-Only Meeting
Aug 10, 2020 04:15PM Zomedica Announces Second Quarter 2020 Financial Results
Aug 7, 2020 06:55AM Zomedica Adds Two New Directors To Board Annual Meeting Materials Availability
Aug 3, 2020 06:56AM Zomedica Pharmaceuticals (ZOM) announces Shameze Rampertab has resigned as Chief Financial Officer
Aug 3, 2020 06:55AM Zomedica Announces Management Change
Jul 21, 2020 04:29PM Zomedica Pharmaceuticals (ZOM) Announces Successful Remote Installation of TRUFORMA
Jul 21, 2020 04:01PM Successful Remote Installation of TRUFORMA™
Jul 7, 2020 04:01PM Zomedica Pharmaceuticals Corp. Closes $30 Million Public Offering
Jul 2, 2020 05:58AM Zomedica Pharmaceuticals (ZOM) Prices 187.5M Share Common Offering at $0.16/Sh
Jul 1, 2020 10:30PM Zomedica Pharmaceuticals Corp. Announces $30 Million Public Offering
Jul 1, 2020 04:04PM Zomedica Pharmaceuticals (ZOM) Announces Proposed Public Offering of Common Stock, Warrants
Jul 1, 2020 04:04PM Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering
Jun 16, 2020 06:05PM Zomedica Appoints New Interim CEO to Lead Organization Through Inaugural Product Launch
May 20, 2020 04:05PM Zomedica Completes Verification of Three More Assays for its TRUFORMA™ Point-of-Care Diagnostic Platform
May 11, 2020 04:20PM Zomedica Announces First Quarter 2020 Financial Results
Apr 21, 2020 06:55AM Zomedica Completes Verification of its TRUFORMA™ Point-of-Care Diagnostic Platform and the First Assay, Canine total T4
Feb 26, 2020 05:24PM Zomedica Pharmaceuticals Corp. Announces Year End 2019 Financial Results
Feb 14, 2020 04:15PM Zomedica Announces Completion of $2.5 Million Registered Direct Offering
Feb 12, 2020 08:47AM Zomedica Pharmaceuticals (ZOM) Announces $2.5 Million Registered Direct Offering of Common Shares, Warrants
Feb 12, 2020 08:43AM Zomedica Announces $2.5 Million Registered Direct Offering
Feb 11, 2020 06:55AM Zomedica Files U.S. Patent Application for Fecal Parasite Detection
Jan 30, 2020 06:55AM Zomedica to Voluntarily Delist its Common Shares from TSX Venture Exchange Effective February 10, 2020
Jan 23, 2020 06:55AM Zomedica to Focus on TRUFORMA™ Commercialization
Jan 20, 2020 06:55AM Zomedica Successfully Completes Development and Manufacturing Milestones for its Cancer Liquid Biopsy Platform
Dec 3, 2019 06:57AM Zomedica Pharmaceuticals (ZOM) announces Gerald Solensky, Jr. has resigned as CEO, Chairman
Dec 3, 2019 06:55AM Zomedica Announces Management Changes
Nov 13, 2019 06:55AM Zomedica Expands ZM-006 Pilot Efficacy Study
Nov 12, 2019 04:53PM Zomedica Announces Third Quarter 2019 Financial Results
Nov 5, 2019 04:15PM Zomedica Announces 2019 Annual Meeting Results
Oct 31, 2019 06:55AM Zomedica Commences Final TRUFORMA™ Diagnostic Verification Study
Sep 17, 2019 06:57AM Zomedica Pharmaceuticals (ZOM) names COO Dr. Stephanie Morley as President
Sep 17, 2019 06:55AM Zomedica names Dr. Stephanie Morley President
Sep 3, 2019 06:55AM Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference
Aug 19, 2019 06:55AM Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors
Aug 8, 2019 04:08PM Zomedica Announces Second Quarter 2019 Financial Results
Aug 7, 2019 06:55AM Zomedica Announces TRUFORMA™ Assay Updates and R&D Expansion
Jul 25, 2019 06:55AM Zomedica’s Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4
Jul 17, 2019 06:55AM Zomedica Announces Initiation of a Digital Data Platform Enhancing its Diagnostic Pipeline
Jun 13, 2019 06:55AM Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform
Jun 12, 2019 04:35PM Zomedica to Present at Raymond James Life Sciences and MedTech Conference
Jun 10, 2019 06:00AM Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares
May 21, 2019 06:55AM Zomedica Announces Achievement of Product Development Milestones on its TRUFORMA™ Point-of-Care Diagnostic Platform
May 10, 2019 05:21PM Zomedica Announces First Quarter 2019 Financial Results
May 10, 2019 06:00AM Zomedica Announces Private Placement of Preferred Shares
View More Recent Stories View Older Stories